Clinical Trials Browser

Phase 2 × Pregabalin × Clear all

NCT06150898 2025-06-13

KePreSt

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

NCT06766916 2025-05-18

CRYSTAL

Phase 2 Recruiting

Head and Neck Neoplasms, Neuralgia

NCT02924675 2019-10-14

LYRORL

Phase 2 Terminated

Earache, Neuralgia

NCT03407430 2018-06-26

Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain

Phase 2 Terminated

11 enrolled 17 charts

Breast Neoplasms, Lymphoma, Pain

NCT02024568 2013-12-31

Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia

Phase 2 Unknown

Myotoxicity, Agnosia, Breast Neoplasms, Pain, Drug-Related Side Effects and Adverse Reactions

NCT00629889 2013-05-22

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Seizures, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

NCT00637975 2011-02-02

Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain

Phase 2 Completed

Neoplasms, Neuralgia, Pain